Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1097/MOP.0000000000000084

http://scihub22266oqcxt.onion/10.1097/MOP.0000000000000084
suck pdf from google scholar
C4137567!4137567!24732566
unlimited free pdf from europmc24732566    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi

pmid24732566      Curr+Opin+Pediatr 2014 ; 26 (3): 286-91
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Venous Thromboembolism in Critically Ill Children #MMPMID24732566
  • Polikoff LA; Faustino EVS
  • Curr Opin Pediatr 2014[Jun]; 26 (3): 286-91 PMID24732566show ga
  • Purpose of review: To review the current literature on venous thromboembolism in critically ill children Recent findings: There is increasing concern for venous thromboembolism and its complications in critically ill children. Critically ill children are at increased risk of thromboembolism because of the treatment that they are receiving and their underlying condition. A complex relationship exists between thrombosis and infection. A thrombus is a nidus for infection while infection increases the risk of thrombosis. Pediatric-specific guidelines for the prevention and treatment of thromboembolism are lacking. Current guidelines are based on data from adults. Novel anticoagulants are now available for use in adults. Studies are ongoing to determine their safety in children. Risk assessment tools have recently been developed to determine the risk of thromboembolism in critically ill children. Certain molecules are associated with thromboembolism in adults. Summary: Pediatric critical care practitioners should be cognizant of the importance of venous thromboembolism in critically ill children to allow for early identification and treatment. Adequately powered clinical trials are critically needed to generate evidence that will guide the treatment and prevention of thromboembolism in critically ill children. Risk assessment tools that incorporate biomarkers may improve our ability to predict the occurrence of thromboembolism in critically ill children.
  • ä


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box